BBAGF (BB Biotech AG) GF Score: 15/100 (As of Jun. 28, 2026) — 40% Below Median


BBAGF BB Biotech AG BBAGF
15 GF Score
Price $76.06
! 4 Warning Signs
View Full Analysis

What is BB Biotech AG GF Score?

BB Biotech AG BBAGF -29.53% 15 GF Score is 15 as of Jun. 28, 2026, which is 40% below its 10-year median of 25.00. GuruFocus rates BBAGF with a GF Score™ of 15/100. The stock has 4 warning signs investors should review.

BB Biotech AG has the GF Score of 15, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 4/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 1/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes BB Biotech AG might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

BB Biotech AG  (OTCPK:BBAGF) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

BB Biotech AG GF Score Related Terms

BBAGF vs VRTX, REGN, ALNY: GF Score Comparison

For the Biotechnology subindustry, BB Biotech AG's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BB Biotech AG GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's GF Score distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's GF Score falls into.


BBAGF
15GF Score
BB Biotech AG BBAGF
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 15 mean?
BB Biotech AG (BBAGF) has a GF Score of 15 as of Jun. 28, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on BB Biotech AG and its competitors. This is 40% below median its historical median of 25.00. Over the past decade, BB Biotech AG's GF Score has ranged from 4.00 to 42.00.
Is BB Biotech AG's GF Score too high?
BB Biotech AG's current GF Score of 15 is 40% below median its 10-year median of 25.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 42.00. Overall, BB Biotech AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's GF Score compare to VRTX and REGN?
BB Biotech AG's GF Score of 15 can be compared against companies in the Biotechnology industry. Historically, BB Biotech AG's own GF Score has ranged from 4.00 to 42.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current GF Score is 15, which is 40% below median its own 10-year median of 25.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (BBAGF) has a current GF Score of 15. The current GF Score is 15, which is 40% below median its 10-year median of 25.00. BB Biotech AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For BB Biotech AG (BBAGF), the current GF Score is 15 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Other Exchanges BION:Switzerland
Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
15GF Score

Get the complete analysis for BBAGF

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$76.06
Price